Drug & Gene Delivery

Bryan received and his PhD in chemical engineering from the University of Delaware. He was a post-doctoral fellow in the department of biochemistry & biophysics at the University of Pennsylvania School of Medicine. Currently Bryan is associate professor of chemical engineering with a joint appointment in biomedical engineering.

Brent A. French combines advanced methods of targeted drug and gene delivery with biomedical imaging in vivo to explore novel targets and treatment strategies in cardiovascular disease. Research interests of the Molecular Bioengineering Lab focus on developing new, more effective strategies for treating and preventing human disease.

John A. Hossack develops ultrasound imaging approaches for cardiovascular disease, including mouse heart imaging, catheter-based imaging and drug delivery, and molecular imaging for diagnosing stroke risk. He obtained B.Eng. and Ph.D. degrees in Electrical and Electronic Engineering, University of Strathclyde and his postdoc at Stanford University.

Kelsey Kubelick leverages light, sound, nanoconstruct design and cellular engineering strategies to develop advanced theranostic imaging platforms. With a special interest in ultrasound and photoacoustics, her lab creates imaging tools that play a critical role in informing, guiding and enhancing therapies across a range of biomedical applications.

Born and raised and educated (all the way past Ph.D.) in Moscow, then USSR, what is now Russia. In 1991 moved to USA and worked in academic research and industrial positions. Research interests are in the area of chemistry applications in biomedical research.